+91-22-48913909Best 10 Performing Sector Funds for 2024
Sector Mutual Funds refer to the scheme that invest a predominant stake of their fund money in equity shares of companies belonging to a particular sector. These schemes are sought after by individuals who are looking for High Returns on their investment along with a High Risk appetite. Some of the sectors in which Mutual Funds generally offer their schemes include infrastructure, pharmaceutical, banking and financial services, and natural resources and new energy. The performance of sectoral funds for the year 2024 has been considerably good. With the developments in the Economy, many of the sectoral funds have generated positive returns on their investments. So, let us look at some of the top and best 10 performing sector Mutual Funds for the year 2024 on the Basis of their performance (returns).
Talk to our investment specialist
Top 10 Performing Sector Mutual Funds for 2024 Based on Performance
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹48.1764
↑ 0.18 ₹1,053 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹289.966
↑ 3.37 ₹1,099 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹420.915
↓ -6.27 ₹3,849 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.3098
↑ 0.36 ₹1,282 40.4 36.6 -8 19.1 64.4 Bandhan Infrastructure Fund Growth ₹49.114
↑ 0.11 ₹1,749 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹247.008
↓ -2.29 ₹7,200 37.3 53.6 -1.9 29.7 27.3 Canara Robeco Infrastructure Growth ₹158.97
↑ 1.06 ₹932 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹507.009
↑ 5.12 ₹8,569 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹62.75
↑ 0.41 ₹1,607 33.2 51.1 2.3 55.4 16.2 Kotak Infrastructure & Economic Reform Fund Growth ₹64.037
↑ 0.64 ₹2,450 32.4 37.3 15.6 57.3 3.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 11 Aug 25 Research Highlights & Commentary of 10 Funds showcased
Commentary LIC MF Infrastructure Fund UTI Healthcare Fund SBI Healthcare Opportunities Fund TATA India Pharma & Healthcare Fund Bandhan Infrastructure Fund Franklin India Opportunities Fund Canara Robeco Infrastructure Nippon India Pharma Fund Invesco India Infrastructure Fund Kotak Infrastructure & Economic Reform Fund Point 1 Bottom quartile AUM (₹1,053 Cr). Bottom quartile AUM (₹1,099 Cr). Upper mid AUM (₹3,849 Cr). Lower mid AUM (₹1,282 Cr). Upper mid AUM (₹1,749 Cr). Top quartile AUM (₹7,200 Cr). Bottom quartile AUM (₹932 Cr). Highest AUM (₹8,569 Cr). Lower mid AUM (₹1,607 Cr). Upper mid AUM (₹2,450 Cr). Point 2 Established history (17+ yrs). Oldest track record among peers (26 yrs). Established history (20+ yrs). Established history (9+ yrs). Established history (14+ yrs). Established history (25+ yrs). Established history (19+ yrs). Established history (21+ yrs). Established history (17+ yrs). Established history (17+ yrs). Point 3 Not Rated. Rating: 1★ (lower mid). Rating: 2★ (upper mid). Not Rated. Top rated. Rating: 3★ (upper mid). Not Rated. Rating: 2★ (lower mid). Rating: 3★ (upper mid). Rating: 4★ (top quartile). Point 4 Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Point 5 5Y return: 31.22% (upper mid). 5Y return: 18.56% (bottom quartile). 5Y return: 20.18% (lower mid). 5Y return: 18.64% (bottom quartile). 5Y return: 32.92% (top quartile). 5Y return: 28.84% (lower mid). 5Y return: 31.61% (top quartile). 5Y return: 18.54% (bottom quartile). 5Y return: 30.00% (upper mid). 5Y return: 30.14% (upper mid). Point 6 3Y return: 27.63% (upper mid). 3Y return: 24.42% (lower mid). 3Y return: 25.58% (lower mid). 3Y return: 21.97% (bottom quartile). 3Y return: 27.94% (top quartile). 3Y return: 29.62% (top quartile). 3Y return: 25.67% (upper mid). 3Y return: 21.64% (bottom quartile). 3Y return: 25.74% (upper mid). 3Y return: 22.67% (bottom quartile). Point 7 1Y return: -4.70% (lower mid). 1Y return: 8.34% (top quartile). 1Y return: 9.20% (top quartile). 1Y return: 1.47% (upper mid). 1Y return: -10.90% (bottom quartile). 1Y return: 1.02% (upper mid). 1Y return: -0.49% (lower mid). 1Y return: 1.24% (upper mid). 1Y return: -5.19% (bottom quartile). 1Y return: -7.59% (bottom quartile). Point 8 Alpha: 0.77 (upper mid). Alpha: 1.14 (upper mid). Alpha: 2.79 (top quartile). Alpha: 2.42 (top quartile). Alpha: 0.00 (upper mid). Alpha: -1.73 (bottom quartile). Alpha: 0.00 (lower mid). Alpha: -2.16 (bottom quartile). Alpha: 0.00 (lower mid). Alpha: -7.48 (bottom quartile). Point 9 Sharpe: -0.02 (upper mid). Sharpe: 0.75 (top quartile). Sharpe: 0.87 (top quartile). Sharpe: 0.47 (upper mid). Sharpe: -0.29 (bottom quartile). Sharpe: -0.09 (lower mid). Sharpe: -0.17 (lower mid). Sharpe: 0.57 (upper mid). Sharpe: -0.22 (bottom quartile). Sharpe: -0.34 (bottom quartile). Point 10 Information ratio: 0.45 (upper mid). Information ratio: -0.29 (bottom quartile). Information ratio: 0.37 (upper mid). Information ratio: 0.73 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: 1.71 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: -0.55 (bottom quartile). Information ratio: 0.00 (bottom quartile). Information ratio: 0.09 (upper mid). LIC MF Infrastructure Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
TATA India Pharma & Healthcare Fund
Bandhan Infrastructure Fund
Franklin India Opportunities Fund
Canara Robeco Infrastructure
Nippon India Pharma Fund
Invesco India Infrastructure Fund
Kotak Infrastructure & Economic Reform Fund
Best Performing Sector Funds for 2024
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. Research Highlights for TATA India Pharma & Healthcare Fund Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Bandhan Infrastructure Fund Below is the key information for Bandhan Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Research Highlights for Franklin India Opportunities Fund Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Canara Robeco Infrastructure Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Research Highlights for Nippon India Pharma Fund Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Research Highlights for Invesco India Infrastructure Fund Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly (at least 65%) equity and equity-related securities of companies involved in economic development of India as a result of potential investments in infrastructure and unfolding economic reforms. Research Highlights for Kotak Infrastructure & Economic Reform Fund Below is the key information for Kotak Infrastructure & Economic Reform Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (11 Aug 25) ₹48.1764 ↑ 0.18 (0.38 %) Net Assets (Cr) ₹1,053 on 30 Jun 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio -0.02 Information Ratio 0.45 Alpha Ratio 0.77 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹16,221 31 Jul 22 ₹18,685 31 Jul 23 ₹23,092 31 Jul 24 ₹42,743 31 Jul 25 ₹40,588 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -4.7% 3 Month 11.4% 6 Month 8.1% 1 Year -4.7% 3 Year 27.6% 5 Year 31.2% 10 Year 15 Year Since launch 9.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.87 Yr. Mahesh Bendre 1 Jul 24 1.08 Yr. Data below for LIC MF Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 48.17% Basic Materials 9.22% Financial Services 6.64% Utility 6.09% Consumer Cyclical 5.19% Technology 4.23% Real Estate 3.53% Health Care 3.22% Communication Services 2.53% Energy 0.91% Asset Allocation
Asset Class Value Cash 9.35% Equity 89.72% Debt 0.93% Other 0% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹45 Cr 475,992
↑ 23,420 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006554% ₹40 Cr 94,287 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Apr 09 | LT4% ₹38 Cr 103,491
↑ 47,984 LIC MF Money Market Dir Gr
Investment Fund | -3% ₹35 Cr 290,520
↑ 290,520 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹34 Cr 769,765
↑ 145,330 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹29 Cr 724,927 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 25 | APOLLOHOSP3% ₹29 Cr 39,867
↑ 39,867 Avalon Technologies Ltd (Technology)
Equity, Since 31 Jul 23 | AVALON3% ₹27 Cr 317,486
↑ 179,935 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | 5341393% ₹27 Cr 319,302
↑ 13,378 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329552% ₹25 Cr 621,524
↑ 50,192 2. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (11 Aug 25) ₹289.966 ↑ 3.37 (1.18 %) Net Assets (Cr) ₹1,099 on 30 Jun 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.75 Information Ratio -0.29 Alpha Ratio 1.14 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹14,212 31 Jul 22 ₹12,434 31 Jul 23 ₹15,086 31 Jul 24 ₹22,089 31 Jul 25 ₹25,028 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -0.5% 3 Month 8% 6 Month 2.8% 1 Year 8.3% 3 Year 24.4% 5 Year 18.6% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.25 Yr. Data below for UTI Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 97.97% Basic Materials 0.93% Asset Allocation
Asset Class Value Cash 1.1% Equity 98.9% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹111 Cr 661,016 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000875% ₹60 Cr 400,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹54 Cr 210,000
↑ 37,171 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹47 Cr 80,283 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY4% ₹46 Cr 360,000
↓ -36,000 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹44 Cr 250,000
↓ -25,250 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | 5002574% ₹39 Cr 200,000
↑ 60,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹38 Cr 53,000
↓ -3,271 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹38 Cr 56,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹37 Cr 465,000 3. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (08 Aug 25) ₹420.915 ↓ -6.27 (-1.47 %) Net Assets (Cr) ₹3,849 on 30 Jun 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.87 Information Ratio 0.37 Alpha Ratio 2.79 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹14,418 31 Jul 22 ₹12,951 31 Jul 23 ₹16,915 31 Jul 24 ₹23,551 31 Jul 25 ₹27,155 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -3.1% 3 Month 1.9% 6 Month -1.2% 1 Year 9.2% 3 Year 25.6% 5 Year 20.2% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.18 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 91.24% Basic Materials 5.74% Asset Allocation
Asset Class Value Cash 2.94% Equity 96.98% Debt 0.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA12% ₹469 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB8% ₹300 Cr 440,000
↑ 27,778 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH7% ₹268 Cr 2,100,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A5% ₹183 Cr 300,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹181 Cr 1,200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002574% ₹163 Cr 840,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND3% ₹130 Cr 560,000 Abbott India Ltd (Healthcare)
Equity, Since 31 Mar 19 | ABBOTINDIA3% ₹128 Cr 36,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | 5328433% ₹127 Cr 1,600,000
↓ -80,000 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | 5409753% ₹125 Cr 2,100,000 4. TATA India Pharma & Healthcare Fund
TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (11 Aug 25) ₹30.3098 ↑ 0.36 (1.19 %) Net Assets (Cr) ₹1,282 on 30 Jun 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.47 Information Ratio 0.73 Alpha Ratio 2.42 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹14,231 31 Jul 22 ₹13,103 31 Jul 23 ₹15,890 31 Jul 24 ₹23,208 31 Jul 25 ₹25,061 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -1.6% 3 Month 4.4% 6 Month -0.1% 1 Year 1.5% 3 Year 22% 5 Year 18.6% 10 Year 15 Year Since launch 12.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Rajat Srivastava 16 Sep 24 0.87 Yr. Data below for TATA India Pharma & Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 89.02% Basic Materials 2.34% Financial Services 0.96% Asset Allocation
Asset Class Value Cash 7.68% Equity 92.32% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA11% ₹143 Cr 854,300 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP7% ₹92 Cr 127,255
↑ 16,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹74 Cr 490,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB6% ₹71 Cr 104,965 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA5% ₹70 Cr 615,100 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹68 Cr 855,100 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹59 Cr 303,240 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | 5409754% ₹57 Cr 956,991 Wockhardt Ltd (Healthcare)
Equity, Since 31 Mar 24 | WOCKPHARMA4% ₹47 Cr 274,871 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹37 Cr 75,249 5. Bandhan Infrastructure Fund
Bandhan Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (11 Aug 25) ₹49.114 ↑ 0.11 (0.22 %) Net Assets (Cr) ₹1,749 on 30 Jun 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio -0.3 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹20,043 31 Jul 22 ₹19,974 31 Jul 23 ₹27,326 31 Jul 24 ₹49,920 31 Jul 25 ₹43,568 Returns for Bandhan Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -4.9% 3 Month 6.1% 6 Month 5.3% 1 Year -10.9% 3 Year 27.9% 5 Year 32.9% 10 Year 15 Year Since launch 11.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for Bandhan Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.52 Yr. Ritika Behera 7 Oct 23 1.82 Yr. Gaurav Satra 7 Jun 24 1.15 Yr. Data below for Bandhan Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 53.42% Utility 12.27% Basic Materials 7.58% Communication Services 4.88% Energy 3.88% Financial Services 3.7% Technology 2.53% Health Care 1.87% Consumer Cyclical 1.71% Real Estate 0.63% Asset Allocation
Asset Class Value Cash 7.52% Equity 92.48% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS6% ₹105 Cr 443,385 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹76 Cr 206,262
↑ 23,089 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹68 Cr 452,706 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹66 Cr 330,018 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA4% ₹61 Cr 4,782,533
↓ -14,610 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325383% ₹61 Cr 50,452 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹60 Cr 1,431,700 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹53 Cr 365,137 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹53 Cr 12,400,122 KEC International Ltd (Industrials)
Equity, Since 30 Jun 24 | 5327143% ₹47 Cr 512,915 6. Franklin India Opportunities Fund
Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (08 Aug 25) ₹247.008 ↓ -2.29 (-0.92 %) Net Assets (Cr) ₹7,200 on 30 Jun 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 2.12 Sharpe Ratio -0.09 Information Ratio 1.71 Alpha Ratio -1.73 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹16,320 31 Jul 22 ₹16,368 31 Jul 23 ₹21,841 31 Jul 24 ₹36,906 31 Jul 25 ₹36,999 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -2.9% 3 Month 4.9% 6 Month 3.9% 1 Year 1% 3 Year 29.6% 5 Year 28.8% 10 Year 15 Year Since launch 13.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 3.48 Yr. R. Janakiraman 1 Apr 13 12.34 Yr. Sandeep Manam 18 Oct 21 3.79 Yr. Data below for Franklin India Opportunities Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Consumer Cyclical 18.52% Financial Services 17.94% Health Care 12.34% Technology 9.85% Basic Materials 8.68% Communication Services 6.9% Energy 6.33% Consumer Defensive 4.94% Industrials 4.27% Utility 2.95% Real Estate 2.17% Asset Allocation
Asset Class Value Cash 5.1% Equity 94.9% Top Securities Holdings / Portfolio
Name Holding Value Quantity Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE6% ₹456 Cr 3,038,968 HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK6% ₹409 Cr 2,043,971 Axis Bank Ltd (Financial Services)
Equity, Since 30 Apr 25 | 5322155% ₹354 Cr 2,950,277
↑ 1,002,248 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL4% ₹270 Cr 1,342,233 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Aug 23 | 5433204% ₹268 Cr 10,130,262
↑ 3,731,849 Hindustan Unilever Ltd (Consumer Defensive)
Equity, Since 30 Jun 24 | HINDUNILVR4% ₹257 Cr 1,121,657 NTPC Ltd (Utilities)
Equity, Since 31 Aug 22 | 5325553% ₹212 Cr 6,333,312
↑ 3,900,867 Maruti Suzuki India Ltd (Consumer Cyclical)
Equity, Since 30 Apr 25 | MARUTI3% ₹210 Cr 169,582
↑ 86,684 HDFC Life Insurance Co Ltd (Financial Services)
Equity, Since 31 Jul 24 | HDFCLIFE3% ₹208 Cr 2,560,258
↑ 447,066 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 May 24 | M&M3% ₹203 Cr 637,966 7. Canara Robeco Infrastructure
Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (11 Aug 25) ₹158.97 ↑ 1.06 (0.67 %) Net Assets (Cr) ₹932 on 30 Jun 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.47 Sharpe Ratio -0.17 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹17,243 31 Jul 22 ₹19,881 31 Jul 23 ₹24,989 31 Jul 24 ₹42,049 31 Jul 25 ₹40,610 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -3.3% 3 Month 8.3% 6 Month 10.9% 1 Year -0.5% 3 Year 25.7% 5 Year 31.6% 10 Year 15 Year Since launch 15.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 4.1 Yr. Shridatta Bhandwaldar 29 Sep 18 6.84 Yr. Data below for Canara Robeco Infrastructure as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 46.39% Utility 12.61% Basic Materials 10.76% Energy 8.36% Financial Services 6.82% Technology 3.87% Communication Services 2.95% Consumer Cyclical 2.85% Real Estate 1.49% Asset Allocation
Asset Class Value Cash 3.9% Equity 96.1% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT8% ₹71 Cr 192,901
↑ 23,500 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹40 Cr 264,250 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Jul 19 | BEL4% ₹39 Cr 919,000 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | 5325554% ₹36 Cr 1,066,480 State Bank of India (Financial Services)
Equity, Since 31 Jul 24 | SBIN4% ₹35 Cr 430,000
↑ 60,000 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO4% ₹35 Cr 58,250 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | 5004003% ₹32 Cr 785,000 Solar Industries India Ltd (Basic Materials)
Equity, Since 28 Feb 25 | SOLARINDS3% ₹30 Cr 16,812 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222753% ₹29 Cr 122,833
↓ -233 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 31 Oct 09 | 5328983% ₹29 Cr 957,546 8. Nippon India Pharma Fund
Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (11 Aug 25) ₹507.009 ↑ 5.12 (1.02 %) Net Assets (Cr) ₹8,569 on 30 Jun 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.88 Sharpe Ratio 0.57 Information Ratio -0.55 Alpha Ratio -2.16 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹14,713 31 Jul 22 ₹13,013 31 Jul 23 ₹16,202 31 Jul 24 ₹23,169 31 Jul 25 ₹25,131 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -3.1% 3 Month 3.5% 6 Month 1% 1 Year 1.2% 3 Year 21.6% 5 Year 18.5% 10 Year 15 Year Since launch 20.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 20.35 Yr. Kinjal Desai 25 May 18 7.19 Yr. Data below for Nippon India Pharma Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 99.47% Asset Allocation
Asset Class Value Cash 0.53% Equity 99.47% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA12% ₹1,048 Cr 6,256,349 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB9% ₹729 Cr 1,070,031
↓ -128,777 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002576% ₹520 Cr 2,683,991
↑ 200,000 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000876% ₹482 Cr 3,200,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP5% ₹470 Cr 648,795 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY5% ₹444 Cr 3,462,170
↓ -200,000 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434274% ₹328 Cr 3,627,277 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO4% ₹311 Cr 919,164
↓ -24,567 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 30 Jun 17 | NH4% ₹304 Cr 1,401,811
↓ -5,135 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433503% ₹284 Cr 2,886,684
↑ 55,120 9. Invesco India Infrastructure Fund
Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (11 Aug 25) ₹62.75 ↑ 0.41 (0.66 %) Net Assets (Cr) ₹1,607 on 30 Jun 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.34 Sharpe Ratio -0.22 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹17,383 31 Jul 22 ₹18,697 31 Jul 23 ₹23,673 31 Jul 24 ₹41,339 31 Jul 25 ₹38,595 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -4.9% 3 Month 7.4% 6 Month 6.6% 1 Year -5.2% 3 Year 25.7% 5 Year 30% 10 Year 15 Year Since launch 10.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 4.91 Yr. Sagar Gandhi 1 Mar 25 0.42 Yr. Data below for Invesco India Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 55.98% Basic Materials 9.28% Consumer Cyclical 8.28% Communication Services 6.52% Utility 6.44% Health Care 4.39% Technology 2.99% Real Estate 2.88% Energy 2.66% Asset Allocation
Asset Class Value Cash 0.59% Equity 99.41% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Aug 21 | BHARTIARTL7% ₹105 Cr 521,351 Supreme Industries Ltd (Industrials)
Equity, Since 30 Apr 24 | 5099304% ₹66 Cr 150,390 Delhivery Ltd (Industrials)
Equity, Since 31 Aug 24 | 5435294% ₹65 Cr 1,698,708 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | 5328984% ₹59 Cr 1,975,592 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390063% ₹56 Cr 35,841 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 30 Nov 24 | POWERINDIA3% ₹55 Cr 27,373 Indian Railway Catering And Tourism Corp Ltd (Industrials)
Equity, Since 30 Apr 24 | IRCTC3% ₹53 Cr 683,788 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 24 | APOLLOHOSP3% ₹52 Cr 71,172 ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical)
Equity, Since 30 Jun 23 | ZFCVINDIA3% ₹50 Cr 37,138
↑ 3,052 Ramco Cements Ltd (Basic Materials)
Equity, Since 31 Jul 23 | RAMCOCEM3% ₹48 Cr 448,912 10. Kotak Infrastructure & Economic Reform Fund
Kotak Infrastructure & Economic Reform Fund
Growth Launch Date 25 Feb 08 NAV (11 Aug 25) ₹64.037 ↑ 0.64 (1.01 %) Net Assets (Cr) ₹2,450 on 30 Jun 25 Category Equity - Sectoral AMC Kotak Mahindra Asset Management Co Ltd Rating ☆☆☆☆ Risk High Expense Ratio 2.17 Sharpe Ratio -0.34 Information Ratio 0.09 Alpha Ratio -7.48 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹17,567 31 Jul 22 ₹20,092 31 Jul 23 ₹27,013 31 Jul 24 ₹43,153 31 Jul 25 ₹38,780 Returns for Kotak Infrastructure & Economic Reform Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Aug 25 Duration Returns 1 Month -5.6% 3 Month 7.9% 6 Month 3.9% 1 Year -7.6% 3 Year 22.7% 5 Year 30.1% 10 Year 15 Year Since launch 11.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 32.4% 2023 37.3% 2022 15.6% 2021 57.3% 2020 3.4% 2019 3.6% 2018 -19.6% 2017 45.3% 2016 9.2% 2015 -0.2% Fund Manager information for Kotak Infrastructure & Economic Reform Fund
Name Since Tenure Nalin Bhatt 1 Oct 23 1.83 Yr. Data below for Kotak Infrastructure & Economic Reform Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 45.64% Basic Materials 16.53% Consumer Cyclical 9.91% Communication Services 9.84% Energy 7.31% Utility 4.75% Financial Services 2.18% Real Estate 2.03% Technology 1.27% Asset Allocation
Asset Class Value Cash 0.52% Equity 99.48% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 20 | BHARTIARTL8% ₹186 Cr 927,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Mar 25 | RELIANCE6% ₹135 Cr 900,000
↑ 450,000 Solar Industries India Ltd (Basic Materials)
Equity, Since 31 Oct 15 | SOLARINDS5% ₹127 Cr 72,000 Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 15 | LT5% ₹114 Cr 310,000 Shree Cement Ltd (Basic Materials)
Equity, Since 31 Dec 11 | 5003874% ₹109 Cr 35,000 InterGlobe Aviation Ltd (Industrials)
Equity, Since 30 Sep 21 | INDIGO3% ₹81 Cr 135,000 Kalpataru Projects International Ltd (Industrials)
Equity, Since 31 Aug 17 | KPIL3% ₹79 Cr 639,927 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 15 | 5325383% ₹73 Cr 60,000 Kajaria Ceramics Ltd (Industrials)
Equity, Since 31 Oct 16 | 5002333% ₹65 Cr 600,000 Bosch Ltd (Consumer Cyclical)
Equity, Since 30 Sep 24 | 5005302% ₹57 Cr 17,500
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved
Research Highlights for LIC MF Infrastructure Fund